查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614065

Dydrogesterone市場：按類型、按應用分類 - 2025-2030 年全球預測

Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年地Dydrogesterone市值為5.6786億美元，預計到2024年將達到6.1812億美元，複合年成長率為9.45%，預計到2030年將達到10.69億美元。

Dydrogesterone是一種合成黃體酮激素，廣泛用於治療各種婦科疾病，如月經失調、不孕症、子宮內膜異位症，以及在反覆流產的情況下支持懷孕。對這些健康問題的認知和診斷的提高正在擴大其應用和最終用途的範圍。對Dydrogesterone的需求主要是由於其安全性和提供與天然黃體酮類似的治療結果的功效，使其成為荷爾蒙補充療法和懷孕支持通訊協定的首選。市場發展很大程度上受到出生率上升、宣導活動活性化和藥物開發進步的影響。鼓勵醫療保健專業人員開出地屈Dydrogesterone作為其他荷爾蒙療法的安全替代品也增加了市場潛力。擴大地理可用性對於新興市場來說是一個機會，因為傳統上荷爾蒙療法的認知度較低。

主要市場統計
基準年[2023] 56786萬美元
預計年份 [2024] 61812萬美元
預測年份 [2030] 10.69億美元
複合年成長率（%） 9.45%

然而，市場受到嚴格的法規環境、學名藥的競爭以及患者和從業者擔心的潛在副作用的限制。價格敏感性和專利到期問題也阻礙了市場擴張，特別是在醫療保健支出預算有限的新興市場。創新的重點是改善給藥機制和減少副作用，並且正在研究最佳化配方以及與數位健康平台的整合，以提高患者的依從性和監測。此外，用於開拓的治療領域的開創性研究可能會擴大市場規模。為了利用這一機遇，公司應專注於策略夥伴關係、投資意識計劃、擴大開拓市場的銷售管道，並加強研究以建立更廣泛的適應症。在對提供安全、有效和方便的治療選擇的創新治療的持續需求的推動下，在監管變化和不斷適應消費者偏好的推動下，市場變得越來越活躍。

市場動態：揭示快速發展的地Dydrogesterone市場的關鍵市場洞察

供需的動態交互作用正在改變地Dydrogesterone市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 老年女性人口的增加和生殖健康問題的蔓延
    • 政府對婦女健康的支持政策
    • 改善各國的醫療基礎設施
  • 市場限制因素
    • 生產地Dydrogesterone的高成本
  • 市場機會
    • Dydrogesterone仿製學名藥核准數量增加
    • 市場參與企業增加投資和業務擴張
  • 市場挑戰
    • 嚴格的地Dydrogesterone藥物核准流程

波特的五力：駕馭地Dydrogesterone市場的策略工具

波特的五力架構是了解地Dydrogesterone市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解地Dydrogesterone市場的外部影響

外部宏觀環境因素在塑造地Dydrogesterone市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解地Dydrogesterone市場的競爭格局

對地Dydrogesterone市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣地Dydrogesterone市場供應商的績效評估

FPNV 定位矩陣是評估地Dydrogesterone市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了地Dydrogesterone市場的成功之路

Dydrogesterone市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性人口老化加劇和生殖健康問題普遍存在
      • 支持婦女健康的政府政策
      • 改善整個經濟領域的醫療基礎設施
    • 抑制因素
      • 生產地Dydrogesterone的成本很高。
    • 機會
      • 學名藥核准增加
      • 市場參與企業增加投資和擴張
    • 任務
      • 與地Dydrogesterone藥物相關的嚴格監管核准流程
  • 市場區隔分析
    • 類型：DydrogesteroneD6在高精度分析和臨床試驗的優勢
    • 用途：Dydrogesterone在婦科疾病症狀緩解和荷爾蒙調節的重要應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章Dydrogesterone市場：依類型

  • DydrogesteroneD5
  • DydrogesteroneD6

第7章地Dydrogesterone市場：依應用分類

  • 婦科疾病
  • 不孕症

第8章美洲地Dydrogesterone市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區地Dydrogesterone市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲地Dydrogesterone市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Theramex 宣布同意從 Viatris 收購 Duphaston 和 Femoston 的歐洲權利
    • Aurisco 奧昔酮（Dydrogesterone）獲得中國首個學名藥核准
    • 美國製藥大廠申請發布改良版藥物，用於治療子宮內膜異位症引起的骨盆腔疼痛
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Adalvo Limited
  • Alembic Pharmaceuticals Limited
  • Axios Research
  • Clearsynth
  • Dr. D Pharma
  • Gufic Group
  • H & Care Incorp
  • Jagsonpal Pharmaceuticals Ltd.
  • Mankind Pharma Limited
  • Medley Pharmaceuticals Ltd.
  • Merck KGaA
  • Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
  • Santa Cruz Biotechnology, Inc.
  • Simson Pharma Limited
  • Solitaire Pharmacia Private Limited
  • Somacare
  • Synokem Pharmaceuticals Ltd.
  • Taj Pharmaceuticals Limited
  • Theramex
  • TLC Pharmaceutical Standards Ltd.
  • Viatris Inc.
  • VIVAN Life Sciences
  • Zuventus Healthcare Limited
Product Code: MRR-144C638C9216

The Dydrogesterone Market was valued at USD 567.86 million in 2023, expected to reach USD 618.12 million in 2024, and is projected to grow at a CAGR of 9.45%, to USD 1,069.00 million by 2030.

Dydrogesterone is a synthetic progesterone hormone widely used in the treatment of various gynecological conditions such as menstrual disorders, infertility, endometriosis, and to support pregnancy in cases of recurrent miscarriage. Increasing awareness and diagnosis of these health issues are expanding its application and end-use scope. The necessity of dydrogesterone is primarily driven by its safety profile and effectiveness in delivering therapeutic outcomes similar to natural progesterone, making it the preferred choice in hormone replacement therapies and pregnancy support protocols. Market growth is significantly influenced by rising fertility rates, increased awareness campaigns, and advancements in pharmaceutical development. The encouragement of healthcare professionals to prescribe dydrogesterone as a safe alternative to other hormone therapy options further cues its market potential. Opportunities lie in the expanding geographical availability in emerging markets where awareness of hormonal therapies was traditionally low.

KEY MARKET STATISTICS
Base Year [2023] USD 567.86 million
Estimated Year [2024] USD 618.12 million
Forecast Year [2030] USD 1,069.00 million
CAGR (%) 9.45%

However, the market is constrained by stringent regulatory environments, generic competition, and potential side effects that are a concern among patients and practitioners. Price sensitivity and patent expiry challenges also hamper market expansion, particularly in developing regions with budget constraints on healthcare spending. Innovations are focused on improving delivery mechanisms and reducing side effects, with ongoing research into optimized formulations and integration with digital health platforms for better patient compliance and monitoring. Additionally, pioneering studies around its use in unexplored therapeutic areas could enhance the market reach. To capitalize on opportunities, companies should focus on strategic partnerships, investing in awareness programs, expanding their distribution channels in underpenetrated markets, and enhancing research to establish broader indications for dydrogesterone use. The market is progressively dynamic, requiring continuous adaptability to regulatory changes and consumer preferences, driven by ongoing demand for innovative therapies that provide safe, effective, and convenient treatment options.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dydrogesterone Market

The Dydrogesterone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing elderly female population and prevalence of reproductive health issues
    • Supportive government policies for women's health
    • Improved healthcare infrastructure across economies
  • Market Restraints
    • High costs associated with dydrogesterone production
  • Market Opportunities
    • Rising approval of generic dydrogesterone drugs
    • Growing investment and expansion by market players
  • Market Challenges
    • Stringent regulatory approval processes associated with dydrogesterone drugs

Porter's Five Forces: A Strategic Tool for Navigating the Dydrogesterone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dydrogesterone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dydrogesterone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dydrogesterone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dydrogesterone Market

A detailed market share analysis in the Dydrogesterone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dydrogesterone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dydrogesterone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dydrogesterone Market

A strategic analysis of the Dydrogesterone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dydrogesterone Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adalvo Limited, Alembic Pharmaceuticals Limited, Axios Research, Clearsynth, Dr. D Pharma, Gufic Group, H & Care Incorp, Jagsonpal Pharmaceuticals Ltd., Mankind Pharma Limited, Medley Pharmaceuticals Ltd., Merck KGaA, Sandoo Pharmaceuticals and Chemcials Co.,Ltd., Santa Cruz Biotechnology, Inc., Simson Pharma Limited, Solitaire Pharmacia Private Limited, Somacare, Synokem Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, Theramex, TLC Pharmaceutical Standards Ltd., Viatris Inc., VIVAN Life Sciences, and Zuventus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Dydrogesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Dydrogesterone D5 and Dydrogesterone D6.
  • Based on Application, market is studied across Gynecological Diseases and Infertility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing elderly female population and prevalence of reproductive health issues
      • 5.1.1.2. Supportive government policies for women's health
      • 5.1.1.3. Improved healthcare infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with dydrogesterone production
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising approval of generic dydrogesterone drugs
      • 5.1.3.2. Growing investment and expansion by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval processes associated with dydrogesterone drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • 5.2.2. Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dydrogesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Dydrogesterone D5
  • 6.3. Dydrogesterone D6

7. Dydrogesterone Market, by Application

  • 7.1. Introduction
  • 7.2. Gynecological Diseases
  • 7.3. Infertility

8. Americas Dydrogesterone Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dydrogesterone Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dydrogesterone Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.
    • 11.3.2. Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China
    • 11.3.3. US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adalvo Limited
  • 3. Alembic Pharmaceuticals Limited
  • 4. Axios Research
  • 5. Clearsynth
  • 6. Dr. D Pharma
  • 7. Gufic Group
  • 8. H & Care Incorp
  • 9. Jagsonpal Pharmaceuticals Ltd.
  • 10. Mankind Pharma Limited
  • 11. Medley Pharmaceuticals Ltd.
  • 12. Merck KGaA
  • 13. Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
  • 14. Santa Cruz Biotechnology, Inc.
  • 15. Simson Pharma Limited
  • 16. Solitaire Pharmacia Private Limited
  • 17. Somacare
  • 18. Synokem Pharmaceuticals Ltd.
  • 19. Taj Pharmaceuticals Limited
  • 20. Theramex
  • 21. TLC Pharmaceutical Standards Ltd.
  • 22. Viatris Inc.
  • 23. VIVAN Life Sciences
  • 24. Zuventus Healthcare Limited

LIST OF FIGURES

  • FIGURE 1. DYDROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. DYDROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DYDROGESTERONE MARKET DYNAMICS
  • TABLE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023